An observational study in Kidney Stone, Infection and Infection Associated With Catheter, sponsored by Ohio State University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-23.
Sponsored by Ohio State University · Observational
Ureteroscopy is the most common surgical treatment for kidney stones. Although rare, sepsis after ureteroscopy can be a life-threatening complication, occuring in \<3% of patients. There are several risk factors for sepsis including history of positive urine culture, pre-existing ureteral stent, or patients with chronic catheters/tubes. the investigators want to study if an antimicrobial solution with chlorhexidine can prevent infections if instilled into the kidney prior to starting ureteroscopy.
605 studies on the registry are indexed under Kidney Calculi; 164 are open to participants now.
This study's planned enrollment of 50 is below the median of 146 across 114 observational studies indexed under Kidney Calculi.
Browse Kidney Calculi studies →Ohio State University is the lead sponsor of 658 studies on the registry; 145 are open to participants now.
Of its 66 completed or terminated interventional studies of FDA-regulated products, 49 (74%) have results posted.
Counted across the registry records on this site, refreshed daily.
anyone who is undergoing ureteroscopy for kidney stone treatment
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Treatment with antimicrobial solution
Drug: antimicrobial irrigation
antimicrobial irrigation to be used with ureteroscopy
Emergency room visits
compare rates of ED visits in the prospective cohort to historic controls
Time frame: 90 days
allergic reaction
any reactions to the antimicrobial solution
Time frame: 30 days
No study locations are listed for this record.
Plan to share: No — This is a proof of concept study with limited outcome data. the investigators will not plan to share individual participant data until later potential randomized prospective trials
Start is estimated for Nov 2026; primary completion for Dec 2026, 1 month later.
Of 39 non-industry observational studies under Kidney Calculi, half reached primary completion within 42 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 59. This study's planned 1 month is below that.
Counting every sponsor, half of 41 studies reached it within 42 months; a quarter within 12 and three quarters within 59.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.